News and Media

Latest News Release
04/13/2021

Cardinal Health (NYSE: CAH) was awarded a $57.8 million contract, including options that if exercised by the U.S. Department of Health and Human Services (HHS) could reach $91.6 million, for the...

Top feature box IMAGE ONLY - COMPANY NEWS

Press Releases

Cardinal Health Partners with CDC to Support Vaccine Access for Pharmacies
11/11/2020

DUBLIN, Ohio, Nov. 11, 2020 /PRNewswire/ -- Cardinal Health (NYSE: CAH) has reached an agreement with the Centers for Disease Control and Prevention (CDC) to act as a network administrator in Phase 2 of the Federal Pharmacy Partnership Strategy for COVID-19, which will enable retail independent, small chains and long-term care pharmacy customers to participate in the vaccination effort. The COVID-19 vaccine will be distributed by the CDC's central distributor.

"Cardinal Health is committed to working with the CDC and our pharmacy customers to ensure a safe and secure COVID-19 vaccine administration network across the United States. The breadth and expertise of Cardinal Health makes us a vital partner to help the country move forward," said Victor Crawford, CEO Pharmaceutical Segment. "Pharmacists are serving on the front line of the national response to the COVID-19 pandemic and are an important part of our nation's fight against the pandemic."

As one of the top healthcare distributors and services providers in the U.S., Cardinal Health will add broad scale, knowledgeable pharmacy expertise and longstanding relationships with pharmacies to this nationwide vaccine distribution effort. Cardinal Health will continue to work with suppliers as well as federal, state and local governments as a trusted healthcare partner to effectively disseminate a COVID-19 vaccine to patients.

About Cardinal

Health
Cardinal Health, Inc. is a global, integrated healthcare services and products company, providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories and physician offices worldwide. The company enhances supply chain efficiency for clinically proven medical products, pharmaceuticals and cost-effective solutions. To combat prescription drug misuse, the Cardinal Health Foundation and its education partners created Generation Rx, a national drug prevention education and awareness program. The Foundation actively supports an array of other solutions, including efforts to reduce opioid prescribing, promote drug take back and safe disposal and expand collaborative community work.

Cardinal Health is backed by nearly 100 years of experience with operations in nearly 46 countries. For more information, visit cardinalhealth.com. Follow us on TwitterFacebook and LinkedIn.

Contacts
Media: Victor Scott at victor.scott01@cardinalhealth.com and 614.783.2408
Investor relations: Kevin Moran at kevin.moran@cardinalhealth.com and 614.757.7942

 

SOURCE Cardinal Health

More Company News
02/02/2023

Revenue increased 13% to $51.5 billion GAAP1 operating loss was $119 million due to a non-cash, pre-tax goodwill impairment of $709 million related to the Medical segment; GAAP diluted loss per...

01/26/2023

The platform will combine and analyze datasets for live purchasing decision support of pharmaceuticals DUBLIN, Ohio and DENVER, Jan. 26, 2023 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced...

01/25/2023

Committed to becoming a more sustainable healthcare partner, the company makes meaningful progress in key ESG areas DUBLIN, Ohio, Jan. 25, 2023 /PRNewswire/ -- Today, Cardinal Health (NYSE: CAH)...

01/03/2023

Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2023 on February 2, prior to the opening of trading on the New York Stock Exchange. The company...

View all company news »